Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Purinergic receptors as potential therapeutic targets in Alzheimer's disease
Lucas T. Woods, Deepa Ajit, Jean M. Camden, et al.
Neuropharmacology (2015) Vol. 104, pp. 169-179
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Pharmacology of Adenosine Receptors: The State of the Art
Pier Andrea Borea, Stefania Gessi, Stefania Merighi, et al.
Physiological Reviews (2018) Vol. 98, Iss. 3, pp. 1591-1625
Open Access | Times Cited: 621
Purinergic Signalling: Therapeutic Developments
Geoffrey Burnstock
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 346
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Geoffrey Burnstock, Gillian E. Knight
Purinergic Signalling (2017) Vol. 14, Iss. 1, pp. 1-18
Open Access | Times Cited: 205
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease
Baban S. Thawkar, Ginpreet Kaur
Journal of Neuroimmunology (2018) Vol. 326, pp. 62-74
Closed Access | Times Cited: 205
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Jifei Miao, Haixia Ma, Yang Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 87
Pathophysiology and management of alzheimer’s disease: an overview
Ajit Kumar Thakur, Parul Kamboj, Kritika Goswami, et al.
Journal of Analytical & Pharmaceutical Research (2018) Vol. 7, Iss. 2
Open Access | Times Cited: 118
The therapeutic potential of purinergic signalling
Geoffrey Burnstock
Biochemical Pharmacology (2017) Vol. 151, pp. 157-165
Closed Access | Times Cited: 117
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes
Maria Elizabeth de Sousa Rodrigues, Madelyn C. Houser, Douglas I. Walker, et al.
Alzheimer s Research & Therapy (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 113
Pathological overproduction: the bad side of adenosine
Pier Andrea Borea, Stefania Gessi, Stefania Merighi, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 13, pp. 1945-1960
Open Access | Times Cited: 108
Calcium-Handling Defects and Neurodegenerative Disease
Sean Schrank, Nikki M. Barrington, Grace E. Stutzmann
Cold Spring Harbor Perspectives in Biology (2019) Vol. 12, Iss. 7, pp. a035212-a035212
Open Access | Times Cited: 89
P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction
Segundo J. Guzman, Zoltán Gerevich
Neural Plasticity (2016) Vol. 2016, pp. 1-12
Open Access | Times Cited: 79
Purine‐related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology
Patricia Alonso‐Andrés, José Luís Albasanz, Isidró Ferrer, et al.
Brain Pathology (2018) Vol. 28, Iss. 6, pp. 933-946
Open Access | Times Cited: 74
Role of purinergic receptors in the Alzheimer’s disease
Marek Cieślak, Andrzej Wojtczak
Purinergic Signalling (2018) Vol. 14, Iss. 4, pp. 331-344
Open Access | Times Cited: 71
Purinergic signaling orchestrating neuron-glia communication
Paula Agostinho, Daniela Madeira, Liliana Dias, et al.
Pharmacological Research (2020) Vol. 162, pp. 105253-105253
Closed Access | Times Cited: 68
Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders
Maria Rosaria Domenici, Antonella Ferrante, Alberto Martire, et al.
Pharmacological Research (2019) Vol. 147, pp. 104338-104338
Closed Access | Times Cited: 60
The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases
Francesco Calzaferri, Cristina Ruiz‐Ruiz, Antonio M. G. de Diego, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 6, pp. 2427-2465
Open Access | Times Cited: 57
Alzheimer’s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation
Shehata Anwar, Serge Rivest
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 4, pp. 331-344
Closed Access | Times Cited: 56
Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications
Hamideh Zarrinmayeh, Paul R. Territo
Molecular Imaging (2020) Vol. 19
Open Access | Times Cited: 54
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
Akihisa Mori, Jiang‐Fan Chen, Shinichi Uchida, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2366-2366
Open Access | Times Cited: 36
Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy
Mariana Alves, Rosa Gómez‐Villafuertes, Norman Delanty, et al.
Epilepsia (2017) Vol. 58, Iss. 9, pp. 1603-1614
Open Access | Times Cited: 56
Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases
Shehata Anwar, Vincent Pons, Serge Rivest
Cells (2020) Vol. 9, Iss. 7, pp. 1595-1595
Open Access | Times Cited: 48
ATP release during seizures – A critical evaluation of the evidence
Edward Beamer, Giorgia Conte, Tobías Engel
Brain Research Bulletin (2019) Vol. 151, pp. 65-73
Closed Access | Times Cited: 47
Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer’s Disease
Rashmi Ranjan Das, Subashchandrabose Chinnathambi
Neuroscience (2020) Vol. 448, pp. 325-336
Closed Access | Times Cited: 40
Profiles of subgingival microbiomes and gingival crevicular metabolic signatures in patients with amnestic mild cognitive impairment and Alzheimer’s disease
Che Qiu, Wei Zhou, Hui Shen, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Blackcurrant (Ribes nigrum L.) and Its Association with Donepezil Restore Cognitive Impairment, Suppress Oxidative Stress and Pro-inflammatory Responses, and Improve Purinergic Signaling in a Scopolamine-Induced Amnesia Model in Mice
Pauline da Costa, Maria Rosa Chitolina Schetinger, Jucimara Baldissarelli, et al.
Neurochemical Research (2025) Vol. 50, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top